BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2506745)

  • 1. Influence of prostaglandin E1 on muscular tissue-PO2 in patients with diabetic gangrene.
    Heinrich R; Krawzak HW; Strosche H
    Adv Exp Med Biol; 1989; 248():699-704. PubMed ID: 2506745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of muscular tissue PO2 after vascular reconstructive surgery.
    Krawzak HW; Heinrich R; Strosche H
    Adv Exp Med Biol; 1989; 248():713-8. PubMed ID: 2782184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
    Belcaro G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):37-43. PubMed ID: 10658443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A; Creutzig H; Alexander K
    Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
    Caspary L; Creutzig A; Alexander K
    Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral oxygenation during prostaglandin E1 induced hypotension.
    Kadoi Y; Saito S; Kunimoto F; Morita T; Goto F; Kawahara F; Fujita N
    Can J Anaesth; 1998 Sep; 45(9):860-4. PubMed ID: 9818109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of normovolemic hemodilution with 10% HES 200 on tissue PO2 in the M. tibialis ant. of 7 male volunteers.
    Heinrich R; Machac N; Günderoth-Palmowski M; Dette S
    Adv Exp Med Biol; 1988; 222():615-22. PubMed ID: 2452558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H; Lammersen T
    Dtsch Med Wochenschr; 1985 Aug; 110(34):1283-5. PubMed ID: 4040847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of dopamine and prostaglandin E1 on portal venous oxygenation].
    Hayakawa J; Itoh T; Kanemura K; Shibata T; Usuda Y
    Masui; 1994 May; 43(5):684-8. PubMed ID: 8015155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation.
    Zywietz F; Reeker W; Kochs E
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1391-400. PubMed ID: 7635779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-arterial infusion therapy of progressive diabetic foot gangrene with prostaglandin E1 amd cefotaxime].
    Krawzak HW; Jäkel F; Strosche H; Buchholz J
    Vasa; 1989; 18(4):312-5. PubMed ID: 2609738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease.
    Naeije R; Mélot C; Mols P; Hallemans R
    Am Rev Respir Dis; 1982 Jan; 125(1):1-5. PubMed ID: 6802045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle PO2 in anaerobic soft tissue infections during hyperbaric oxygen therapy.
    van der Kleij AJ; Bakker DJ; Lubbers M; Henny CP
    Adv Exp Med Biol; 1992; 317():125-9. PubMed ID: 1288119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of prostaglandin E1 on amino acid metabolism of human skeletal muscle].
    Stiegler H; Wicklmayr M; Rett K; Mehnert H
    Klin Wochenschr; 1990 Apr; 68(7):380-3. PubMed ID: 2342320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of preoperative administration of prostaglandin E1 on cerebral blood flow in newborns with ductal-dependent congenital cardiac malformations].
    Simon M; Cucerea M; Dimitriu AG; Stamatin M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):399-407. PubMed ID: 20700975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
    Itoh Y; Yasui T; Kakizawa H; Makino M; Fujiwara K; Kato T; Imamura S; Yamamoto K; Hishida H; Nakai A; Itoh M; Nagasaka A
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Int J Microcirc Clin Exp; 1991 Aug; 10(3):231-40. PubMed ID: 1955281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.